Ketazolam API Manufacturers
compare suppliers & get competitive offers
Filters
Reset
Selected filters:
Type
Production region
Qualifications
To view suppliers for this material, you need to be logged in first.
This is because of international laws regarding narcotic materials. Furthermore, the contents of this page are only accessible if you are professionaly active in the pharmaceutical industry. In case you are, it is possible to register on our platform, and after your account is approved by our team you will be able to view suppliers and send your request.
Looking for Ketazolam API 27223-35-4?
- Description:
- Here you will find a list of producers, manufacturers and traders of Ketazolam. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Ketazolam
- Synonyms:
- Ketazolam
- Cas Number:
- 27223-35-4
- DrugBank number:
- DB01587
- Unique Ingredient Identifier:
- 92A214MD7Y
About Ketazolam
It's time for some technical information for the ones who understand chemistry: Ketazolam is a benzodiazepine derivative with anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant activity. Ketazolam is not approved in Canada or America.
You can ask the supplier about all relevant certificates for the product such as CoA, Safety Data Sheet and DMF.
Ketazolam is a type of Benzodiazepines
Benzodiazepines are a class of pharmaceutical APIs (active pharmaceutical ingredients) widely used in the treatment of various medical conditions. These compounds belong to the family of psychoactive drugs and are primarily known for their anxiolytic (anti-anxiety), sedative, hypnotic, and muscle relaxant properties.
Benzodiazepines work by enhancing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter in the brain that helps regulate neuronal excitability. By increasing the effects of GABA, benzodiazepines promote relaxation, reduce anxiety, and induce sleep. Due to their effectiveness, benzodiazepines have become a key therapeutic option for treating anxiety disorders, panic attacks, insomnia, seizures, and muscle spasms.
The pharmaceutical industry offers a wide range of benzodiazepine APIs, including well-known compounds like diazepam, lorazepam, alprazolam, and clonazepam. These APIs are typically synthesized through complex chemical processes and must adhere to stringent quality standards to ensure their purity, potency, and safety.
Benzodiazepines are commonly formulated into oral tablets, capsules, or liquids for easy administration. They are available under various brand names and may require a prescription due to their potential for misuse and dependence. The dosage and duration of benzodiazepine treatment should be carefully determined by healthcare professionals to minimize the risk of adverse effects.
It is important to note that benzodiazepines may cause side effects such as drowsiness, dizziness, impaired coordination, and memory problems. Long-term use or sudden discontinuation of benzodiazepines can lead to withdrawal symptoms and should be managed under medical supervision.
In summary, benzodiazepines are a crucial category of pharmaceutical APIs used to alleviate anxiety, induce sleep, and relax muscles. They play a significant role in the treatment of various medical conditions, but their usage requires careful monitoring and adherence to medical guidelines to ensure safe and effective outcomes for patients.
